Small molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma (RNAseq dataset)

ABSTRACT: This study utilised a range of different Group 3 subtype II and SHH-alpha models of medulloblastoma. RNAseq was performed on all models. Most have already been published as cited in the manuscript, but data for those unpublished previously are reported here.

PROVIDER: EGAS00001004748 | EGA |

REPOSITORIES: EGA